- Home
- LYB vs ASND Comparison
LYB vs ASND Comparison
Compare LYB & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LYB | ASND |
|---|---|---|
| Founded | 1955 | 2006 |
| Country | Netherlands | Denmark |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.2B | 17.7B |
| IPO Year | 2010 | 2014 |
Fundamental Metrics
Financial Performance| Metric | LYB | ASND |
|---|---|---|
| Price | $59.05 | $228.09 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 19 | 20 |
| Target Price | $67.94 | ★ $309.22 |
| AVG Volume (30 Days) | ★ 2.3M | 798.1K |
| Earning Date | 10-30-2026 | 11-11-2026 |
| Dividend Yield | ★ 4.71% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.10 | N/A |
| Revenue | ★ $30,153,000,000.00 | N/A |
| Revenue This Year | $10.29 | $90.32 |
| Revenue Next Year | N/A | $46.90 |
| P/E Ratio | $27.52 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $41.58 | $186.05 |
| 52 Week High | $83.94 | $282.15 |
Technical Indicators
Market Signals| Indicator | LYB | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 42.92 | 38.67 |
| Support Level | $57.85 | $214.28 |
| Resistance Level | $60.33 | $246.56 |
| Average True Range (ATR) | 1.61 | 9.23 |
| MACD | -0.42 | -1.29 |
| Stochastic Oscillator | 35.14 | 22.33 |
Price Performance
Historical ComparisonAbout LYB LyondellBasell Industries NV (Netherlands)
LyondellBasell is a petrochemical producer with operations in the United States, Europe, and Asia. The company is the world's largest producer of polypropylene and also a major producer of polyethylene and propylene oxide. Its chemicals are used in various consumer and industrial end products. Well over half of LyondellBasell's production comes from its North American operations.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.